Status:

UNKNOWN

A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Lead Sponsor:

NeoVista

Conditions:

Macular Degeneration

Eligibility:

All Genders

50+ years

Phase:

PHASE3

Brief Summary

The objective of the CABERNET Trial is to evaluate the safety and efficacy of focal delivery of radiation for the treatment of subfoveal choroidal neovascularization (CNV) associated with wet age-rela...

Detailed Description

Therapeutic advances in the arena of neovascular age-related macular degeneration (AMD) have provided multiple treatment options for the disease. Radiotherapy has been studied in multiple clinical tri...

Eligibility Criteria

Inclusion

  • Subjects must have predominantly classic, minimally classic, or occult with no classic lesions, as determined by the Investigator, secondary to AMD, with a total lesion size (including blood, scarring, and neovascularization) of \< 12 total disc areas (21.24 mm2), and a GLD ≤5.4 mm
  • Subjects must be age 50 or older

Exclusion

  • Subjects with prior or concurrent subfoveal CNV therapy including thermal laser photocoagulation (with or without photographic evidence), photodynamic therapy, injections with Macugen®, intravitreal or subretinal steroids, transpupillary thermotherapy (TTT), and systemic anti-angiogenic or intravitreal anti-angiogenic agents in study eye. (Note: This includes subjects with no known history, but with photographic evidence of prior therapy)
  • Subjects who underwent previous radiation therapy to the eye, head or neck
  • Subjects that have been previously diagnosed or have retinal findings consistent with Type 1 or Type 2 Diabetes Mellitus

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

494 Patients enrolled

Trial Details

Trial ID

NCT00454389

Start Date

April 1 2007

End Date

August 1 2012

Last Update

July 27 2011

Active Locations (32)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (32 locations)

1

Retinal Consultants of Arizona

Phoenix, Arizona, United States, 85014

2

Retina Center, PC

Tucson, Arizona, United States, 85704

3

Retina-Vitreous Associates Medical

Beverly Hills, California, United States, 90211

4

Retinal Diagnostic Center

Campbell, California, United States, 95008